NCT07180342 An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities Status RECRUITING Phase NA
NCT07174557 Remote Evaluation and Alerting for Collaborative Health (REACH) in Depression Status RECRUITING Phase NA
NCT07136714 Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity Status RECRUITING Phase PHASE4
NCT07115329 A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder Status RECRUITING Phase PHASE2
NCT07111390 Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) Status RECRUITING Phase NA
NCT07105111 A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Status RECRUITING Phase PHASE4
NCT07088380 Ketamine Augmentation of ECT in Treatment-Resistant Depression Status RECRUITING Phase PHASE3
NCT07076407 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) Status RECRUITING Phase PHASE3
NCT07051746 Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in Taiwan Status COMPLETED Phase NA
NCT07028216 Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method Status RECRUITING Phase NA
NCT07002684 Metabolic Profiling of Esketamine Treatment in Depressive Disorder Status RECRUITING Phase N/A
NCT06979154 Pilot Study of Personalized Aperiodic Transcranial Alternating Current Stimulation in Antenatal Depression (PandA-tACS) Status COMPLETED Phase NA
NCT06976840 Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments Status RECRUITING Phase NA
NCT06966401 Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3
NCT06964711 GW117 ODT (Orally Disintegrating Tablets) Safety and Pharmacokinetics Study in Healthy Subjects Status COMPLETED Phase PHASE1
NCT06963021 NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) Status RECRUITING Phase PHASE3